D P Ruiz-Genao, G Carretero, R Rivera, C Ferrándiz, E Daudén, P de la Cueva, I Belinchón, F J Gómez-García, E Herrera-Acosta, J L López-Estebaranz, M Ferrán-Farrés, M Alsina, O Baniandrés-Rodríguez, J L Sánchez-Carazo, A Sahuquillo-Torralba, L Rodriguez, J Vilar-Alejo, C García-Donoso, J M Carrascosa, M Llamas-Velasco, E Herrera-Ceballos, R Botella-Estrada, M A Descalzo, I García-Doval
BACKGROUND AND OBJECTIVES: Current psoriasis guidelines do not usually include recommendations about first line classical or biologic treatment. The objectives of this study were: to describe shifts in the prescription of the first biological treatment, and to compare treatment withdrawal and rates of adverse events over ten years Methods: Biobadaderm registry was analyzed to describe: first biological prescription in bio-naïve patients, adverse events rate and reasons for drug withdrawal comparing three periods of time (2008-2010, 2011-2014, 2015-2018)...
October 12, 2020: Actas Dermo-sifiliográficas